The gas metallicity gradient and the star formation activity of disc galaxies

We study oxygen abundance profiles of the gaseous disc components in simulated galaxies in a hierarchical universe. We analyse the disc metallicity gradients in relation to the stellar masses and star formation rates of the simulated galaxies. We find a trend for galaxies with low stellar masses to have steeper metallicity gradients than galaxies with high stellar masses at z ~0. We also detect that the gas-phase metallicity slopes and the specific star formation rate (sSFR) of our simulated disc galaxies are consistent with recently reported observations at z ~0. Simulated galaxies with high stellar masses reproduce the observed relationship at all analysed redshifts and have an increasing contribution of discs with positive metallicity slopes with increasing redshift. Simulated galaxies with low stellar masses a have larger fraction of negative metallicity gradients with increasing redshift. Simulated galaxies with positive or very negative metallicity slopes exhibit disturbed morphologies and/or have a close neighbour. We analyse the evolution of the slope of the oxygen profile and sSFR for a gas-rich galaxy-galaxy encounter, finding that this kind of events could generate either positive and negative gas-phase oxygen profiles depending on their state of evolution. Our results support claims that the determination of reliable metallicity gradients as a function of redshift is a key piece of information to understand galaxy formation and set constrains on the subgrid physics.Comment: 12 pages, 8 figures, accepted MNRA

Biosafety test for plant growth-promoting bacteria: proposed environmental and human safety index (EHSI) protocol

Plant growth-promoting bacteria (PGPB) colonize plants and enhance their growth by different mechanisms. Some of these microorganisms may represent a potential threat to human, animal or plant health; however, their use might be approved in parts of Europe if they have been recommended as plant growth enhancers. The current regulatory framework has resulted in a fragmented, contradictory system, and there is an urgent need to establish harmonized protocols for the predictability, efficiency, consistency and especially the safety of PGPB for human and animal health and for the environment. In response to current efforts to update biosafety policies and provide alternative methods to replace the use of vertebrate animals, we propose a panel of tests and an evaluation system to reliably determine the biosafety of bacterial strains used as PGPB. Based on the results of different tests, we propose a scoring system to evaluate the safety of candidates for PGPB within the limitations of the assays used.Peer reviewe

Genomic effects of a nanostructured alumina insecticide in human peripheral blood lymphocytes in vitro

Nanotechnology is providing new tools for precision agriculture, such as agrochemical agents and innovative delivery mechanisms to improve cropping efficiency. Powder nanoinsecticides, such as experimental nanostructured alumina (NSA), show great potential for sustainable agriculture as an alternative to conventional synthetic pesticides because their mechanism of insecticide action is based on physical rather than on biochemical phenomena. However, even in highly non-reactive and hardly soluble substances such as alumina, reduced particle size may lead to an increased toxicity of the material. In order to determine whether NSA induces DNA and chromosomal damage, its toxicity was assessed in human peripheral blood lymphocytes (PBL) and contrasted with commercial nanostructured alumina, natural insecticide powders and a conventional pesticide. PBL from healthy donors were exposed for 24 h to increasing concentrations (50, 100 and 200 μg/mL) of NSA particle agglomerates (<350 nm); positive and negative NSA-particles, respectively; bulk Al2O3 (4.5 μm) or Diatomaceous Earth (SiO2, <4.5 μm). Alkaline comet assay and micronuclei (MNi) test were used to assess DNA damage and chromosomal breakage, respectively. Cell viability was tested with resazurin assay. Comet assay results revealed no significant increase in DNA damage by NSA compared to other natural substances. As expected, DNA breaks were significantly higher in cells exposed to an organophosphate [OPP] control (P < 0.05). No statistically significant differences were found in terms of cellular viability at 50 and 100 μg/mL of NSA but cell survival decreased at 200 μg/mL as well as in OPP group. Positively charged NSA particles significantly reduced cell viability and increased DNA migration and oxidative DNA damage (8-oxoG). NSA as well as the electrically charged NSA particles had no significant effect on MNi induction. Our results indicate that NSA particles are non-cytotoxic and non-genotoxic at the tested doses and do not cause obvious DNA damage in human PBL in vitro.Fil: Vilchez Aruani, Juan. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; ArgentinaFil: Cuello Carrión, Fernando Darío. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; ArgentinaFil: Valdez, Susana Ruth. Universidad Nacional de Cuyo. Facultad de Ciencias Exactas y Naturales; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; ArgentinaFil: Nadin, Silvina Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; Argentina. Universidad Nacional de Cuyo; Argentin

The parasporal crystals of Bacillus pumilus strain 15.1: a potential virulence factor?

Bacillus pumilus strain 15.1 was previously found to cause larval mortality in the Med-fly 27 Ceratitis capitata and was shown to produce crystals in association with the spore. As 28 parasporal crystals are well-known as invertebrate-active toxins in entomopathogenic 29 bacteria such as Bacillus thuringiensis (Cry and Cyt toxins) and Lysinibacillus sphaericus (Bin 30 and Cry toxins), the B. pumilus crystals were characterised. The crystals were composed of a 31 45 kDa protein that was identified as an oxalate decarboxylase by peptide mass 32 fingerprinting, N-terminal sequencing and by comparison with the genome sequence of strain 33 15.1. Synthesis of crystals by a plasmid-cured derivative of strain 15.1 (produced using a 34 novel curing strategy), demonstrated that the oxalate decarboxylase was encoded 35 chromosomally. Crystals spontaneously solubilized when kept at low temperatures and the 36 protein produced was resistant to trypsin treatment. The insoluble crystals produced by 37 B. pumilus 15.1 did not show significant toxicity when bioassayed against C. capitata larvae, 38 but once the OxdD protein was solubilized, an increase of toxicity was observed. We also 39 demonstrate that the OxdD present in the crystals has oxalate decarboxylate activity as the 40 formation of formate was detected, which suggests a possible mechanism for B. pumilus 15.1 41 activity. To our knowledge, the characterization of the B. pumilus crystals as oxalate 42 decarboxylase is the first report of the natural production of parasporal inclusions of an 43 enzyme

Using phage display technology to obtain Crybodies active against non-target insects

The insecticidal Cry toxins produced by Bacillus thuringiensis (Bt) are increasingly important in the biological control of insect pests and vectors of human disease. Markets for Bt products and transgenic plants expressing their toxins are driven by their specificity, safety and the move away from chemical control agents. However, the high specificity of Cry toxins can also prove to be a limitation when there is no known Cry toxin active against a particular target. Novel activities can be discovered by screening natural Bt isolates or through modifications of the Cry proteins. Here we demonstrate the use of λ-phage displaying Cry1Aa13 toxin variants modified in domain II loop 2 (Crybodies) to select retargeted toxins. Through biopanning using gut tissue from larvae of the non-target insect Aedes aegypti, we isolated a number of phage for further testing. Two of the overexpressed Cry toxin variants showed significant activity against A. aegypti larvae while another induced mortality at the pupal stage. We present the first report of the use of phage display to identify novel activities toward insects from distant taxonomic Orders and establish this technology based on the use of Crybodies as a powerful tool for developing tailor-made insecticides against new target insects

Modelo prolab: Dr. Phuyu, propuesta de digitalización de historias clínicas

Actualmente el sector de salud público está en un proceso de implementación de la historia clínica electrónica (HCE) mediante el Plan de Implementación del Registro Nacional de Historias Clínicas Electrónicas – RENHICE (Resolución Ministerial N° 618-2019/MINSA), mientras que en el sector privado existen solamente algunas clínicas o grupos clínicos que tienen su propia HCE. En la actualidad las historias clínicas son manuscritas y este proceso presenta varias falencias en el Perú país y en la región de Latinoamérica. Por ello, proponemos un negocio digital para incorporar eficiencia a los procesos administrativos de los policlínicos y consultorios médicos, proponiendo el seguimiento de la trazabilidad administrativa y médica del paciente mediante una HCE que agilice tiempos, disminuya costos operativos, genere transparencia de información, beneficie a las Instituciones Prestadoras de Servicios de Salud (IPRESS) y beneficie al usuario final que son los pacientes. La idea del proyecto Dr. Phuyu (Phuyu = nube en quechua) es integrar las HCE del sector público y privado en una plataforma tecnológica que permitiría una administración transparente de las HCE mediante el uso de un software con aplicaciones modernas, compatibles e integradas al MINSA. Finalmente, los resultados financieros demuestran la viabilidad del proyecto obteniendo una VAN de S/. 1,000,040.00, una TIR de 91% y un posible costo de oportunidad de los inversionistas de 22%. En paralelo el proyecto proyecta un VAN Social de S/. 472,088.76 y para ello se consideró el tiempo ahorrado del personal administrativo y médico de los policlínicos, consultorios médicos y pacientes.Nowadays the Peruvian Public Health sector is immersing in the implementation process of an Electronic Health Record (EHC). This implementation is part of a structured and designed plan named Registro Nacional de Historias Clínicas Electrónicas – RENHICE (Resolución Ministerial N° 618-2019/MINSA). Although there are some private health institutions that has their own EHC, there is not a universal EHC which could englobe the private and public health centers in one solid structure. Currently in almost every region of Peru, the health institutions use a handwritten medical history (HMH) to register their patients and their medical history. However, this process presents many failures and defects. That is why the idea of a new disruptive business that could benefit the healthcare centers (policlinics), the independent doctors (doctor’s office), and the patients, all together, will improve and organize the crucial sector of health in Peru. Dr. Phuyu is our business model which would be able to measure the administrative and medical record of any patient through the EHC. Furthermore, will permit to decrease operating costs, to speed up time, and to have a clear information in your hand. Dr. Phuyu gathers all these improvements in beneficial of the Instituciones Prestadoras de Servicios de Salud (IPRESS) and the patients. Dr. Phuyu will incorporate the public and private EHC in a modern, friendly, well organized, and useful platform, which will be connected with the MINSA. Finally, financial results demonstrate the economic viability of the project with a VAN of S/. 1,000,040.00, a TIR of 91% and a possible opportunity cost of 22% for the investors

Muscle imaging in laminopathies: Synthesis study identifies meaningful muscles for follow-up

Introduction: Particular fibroadipose infiltration patterns have been recently described by muscle imaging in congenital and later onset forms of LMNA-related muscular dystrophies (LMNA-RD). Methods: Scores for fibroadipose infiltration of 23 lower limb muscles in 34 patients with LMNA-RD were collected from heat maps of 2 previous studies. Scoring systems were homogenized. Relationships between muscle infiltration and disease duration and age of onset were modeled with random forests. Results: The pattern of infiltration differs according to disease duration but not to age of disease onset. The muscles whose progression best predicts disease duration were semitendinosus, biceps femoris long head, gluteus medius, and semimembranosus. Discussion: In LMNA-RD, our synthetic analysis of lower limb muscle infiltration did not find major differences between forms with different ages of onset but allowed the identification of muscles with characteristic infiltration during disease progression. Monitoring of these specific muscles by quantitative MRI may provide useful imaging biomarkers in LMNA-RD. Muscle Nerve 58:812-817, 201

Cutibacterium spp. Infections after Instrumented Spine Surgery Have a Good Prognosis Regardless of Rifampin Use: A Cross-Sectional Study

Infection after spinal instrumentation (IASI) by Cutibacterium spp. is being more frequently reported. The aim of this study was to analyse the incidence, risk factors, clinical characteristics, and outcome of a Cutibacterium spp. IASI (CG) compared with non-Cutibacterium IASI (NCG) infections, with an additional focus on the role of rifampin in the treatment. All patients from a multicentre, retrospective, observational study with a confirmed IASI between January 2010 and December 2016 were divided into two groups: (CG and NCG) IASI. Baseline, medical, surgical, infection treatment, and follow-up data were compared for both groups. In total, 411 patients were included: 27 CG and 384 NCG. The CG patients were significantly younger. They had a longer median time to diagnosis (23 vs. 13 days) (p = 0.025), although 55.6% debuted within the first month after surgery. Cutibacterium patients were more likely to have the implant removed (29.6% vs. 12.8%; p = 0.014) and received shorter antibiotic regimens (p = 0.014). In 33% of Cutibacterium cases, rifampin was added to the baseline therapy. None of the 27 infections resulted in treatment failure during follow-up regardless of rifampin use. Cutibacterium spp. is associated with a younger age and may cause both early and late IASIs. In our experience, the use of rifampin to improve the outcome in the treatment of a Cutibacterium spp. IASI is not relevant since, in our series, none of the cases had therapeutic failure regardless of the use of rifampin

Infections after spine instrumentation: effectiveness of short antibiotic treatment in a large multicentre cohort

REIPI (Spanish Network for Research in Infectious Disease)/GEIO–SEIMC (Group for the Study of Osteoarticular Infections – Spanish Society of Infectious Diseases and Clinical Microbiology).[Background and objectives] Available information about infection after spine instrumentation (IASI) and its management are scarce. We aimed to analyse DAIR (debridement, antibiotics and implant retention) prognosis and evaluate effectiveness of short antibiotic courses on early forms.[Methods] Multicentre retrospective study of patients with IASI managed surgically (January 2010–December 2016). Risk factors for failure were analysed by multivariate Cox regression and differences between short and long antibiotic treatment were evaluated with a propensity score-matched analysis.[Results] Of the 411 IASI cases, 300 (73%) presented in the first month after surgery, 48 in the second month, 22 in the third and 41 thereafter. Infections within the first 2 months (early cases) occurred mainly to older patients, with local inflammatory signs and predominance of Enterobacteriaceae, unlike those in the later periods. When managed with DAIR, prognosis of early cases was better than later ones (failure rate 10.4% versus 26.1%, respectively; P = 0.02). Risk factors for DAIR failure in early cases were female sex, Charlson Score, large fusions (>6 levels) and polymicrobial infections (adjusted HRs of 2.4, 1.3, 2.6 and 2.26, respectively). Propensity score matching proved shorter courses of antibiotics (4–6 weeks) as effective as longer courses (failure rates 11.4% and 10.5%, respectively; P = 0.870).[Conclusions] IASIs within the first 2 months could be managed effectively with DAIR and shorter antibiotic courses. Clinicians should be cautious when faced with patients with comorbidities, large fusions and/or polymicrobial infections.E.B. was supported with a grant of the Instituto de Salud Carlos III – Ministry of Science and Innovation (FI 16/00397). This research was carried out as part of our routine work.Peer reviewe